BioNxt Solutions Inc.
BNXT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.86% | 48.84% | -2.67% | 59.43% | -5.51% |
| Total Depreciation and Amortization | -123.84% | -48.42% | -53.19% | -59.17% | -53.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 318.21% | -16.36% | 34.48% | -66.85% | 47.39% |
| Change in Net Operating Assets | -223.48% | -128.21% | 1,496.24% | -157.01% | 205.24% |
| Cash from Operations | -25.12% | 18.68% | 78.97% | 40.55% | 37.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | 147.79% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -11,010.75% | -- | -- | -- |
| Issuance of Common Stock | -82.42% | -85.38% | -100.00% | -- | -78.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3,152.12% | -89.67% | 100.00% | -- | 74.18% |
| Cash from Financing | 103.17% | 19.92% | -100.00% | 502.81% | -78.79% |
| Foreign Exchange rate Adjustments | 500.00% | -88.89% | 158.33% | 111.11% | -94.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.18% | 80.33% | -189.57% | 114.42% | -116.05% |